COHEN ppt 2012

51
CROSS SECTION TRICHOMETRY UPDATE A NEW TOOL FOR MANAGING PATIENTS WITH HAIR LOSS ISHRS – ANNUAL SCIENTIFIC MEETING Nassau, Bahamas – October 18-21, 2012 Bernard Cohen, MD Diplomate, American Board of Dermatology Diplomate, American Board of Hair Restoration Surgery

Transcript of COHEN ppt 2012

Page 1: COHEN ppt 2012

CROSS SECTIONTRICHOMETRY

UPDATEA NEW TOOL FOR MANAGING

PATIENTS WITH HAIR LOSS

ISHRS – ANNUAL SCIENTIFIC MEETINGNassau, Bahamas – October 18-21, 2012

Bernard Cohen, MD

Diplomate, American Board of Dermatology Diplomate, American Board of Hair Restoration Surgery

Page 2: COHEN ppt 2012
Page 3: COHEN ppt 2012

Disclosure:Speaker owns US and foreign patentspertaining to Trichometer technology.

Page 4: COHEN ppt 2012

HAIR MASSTrichometry measures

“HOW MUCH HAIR”is actually present

Based on density and diameter.(...and not density alone)

Page 5: COHEN ppt 2012

2006 TRICHOMETER PROTOTYPE

Page 6: COHEN ppt 2012
Page 7: COHEN ppt 2012

Commercially available Trichometer

Page 8: COHEN ppt 2012

Chapter 11C

Unger & Shapiro“Hair Transplantation”

5th edition

Page 9: COHEN ppt 2012

DIAMETER – smaller and smaller FOLLICLE – smaller and smaller ANAGEN PHASE – shorter and shorter

AGA or Thinning

Page 10: COHEN ppt 2012

HAIR DENSITY COUNTAVERAGE DENSITY = 230 HAIRS /CM2

NORMAL SCALP BALDING SCALP

Page 11: COHEN ppt 2012

CROSS SECTION TRICHOMETRY

How it works...

Page 12: COHEN ppt 2012

Locating strip & 4 legged inked template

Page 13: COHEN ppt 2012

2 X 2cm area is defined by 4 dotsHair is isolated

Page 14: COHEN ppt 2012

Arms open – Hook extendsArms closed – Hook retracts

Page 15: COHEN ppt 2012

1. Hook capturesbundle

2. Arms areclosed

3. Hook retracts

4. Bundle is compressed

Page 16: COHEN ppt 2012

HMI displayed on LED screen

Page 17: COHEN ppt 2012

HMI (HAIR MASS INDEX)

mm2 of hair / cm2 of scalp

Normal range:75 fine hair

100 coarse hair

.

Page 18: COHEN ppt 2012

HMI(BUNDLE CROSS SECTION)

will change if or when

A full-sized hair falls outA miniaturized hair eventually vanishesA full-sized hair emerges from the skin

A hair diameter increasesA hair diameter decreases

Page 19: COHEN ppt 2012

CROSS SECTION TRICHOMETERY

AccuratePrecise

ReproducibleSensitive

Fast & EasyNo hair is cut

Works equally well for shedding or thinningEquivalent to dry hair weight

(INDUSTRY GOLD STANDARD LAB TEST)

Page 20: COHEN ppt 2012

THE MEDICAL MANAGEMENT OF HAIR LOSS IS

SUDDENLY SIMPLE!

INDIVIDUALLY

Page 21: COHEN ppt 2012

CROSS SECTIONTRICHOMETRY

PROVIDES

QUANTITATIVE FEEDBACK

INDIVIDUALLY

Page 22: COHEN ppt 2012

With CST you’ll be able to answer these questions:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 23: COHEN ppt 2012

BASELINE

4972 65

ONE YEAR LATER

72-65/72= 10% WORSENING IN ONE YEAR

Page 24: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Should I advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 25: COHEN ppt 2012

BASELINE

4978 71

AFTER ONE YEAR OF MNX

TIME TO CONSIDER ADVANCING TO FINASTERIDE

Page 26: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 27: COHEN ppt 2012

on FINASTERIDE 1mgm daily reduce to1mgm 2x/wk

4963 62

Theoretical example – NOT clinical observation

One year later

Page 28: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 29: COHEN ppt 2012

MNX 2% bid x 1 yearChange to MNX 5% once

daily

4975 79

MNX 5% once dailyat end of following year

Theoretical example – NOT clinical observation

Page 30: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 31: COHEN ppt 2012

MNX 5% genericat end of year #1

Switch to Rogaine 5%

4961 62

Rogaine 5%at end of following year

Theoretical example – NOT clinical observation

Page 32: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 33: COHEN ppt 2012

On MNX 5%Switch to MNX + RetinA

4972 79

One year later

Page 34: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 35: COHEN ppt 2012

On MNX 5% bid x 3 yearsthen switch patient

to Laser Rx

4963 61

24 MONTHS LATER

Theoretical example – NOT clinical observation

Page 36: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 37: COHEN ppt 2012

FIN 1mgm daily

4957 58

FIN 1 mgm dailyplus Laser Rx

Theoretical example – NOT clinical observation

Page 38: COHEN ppt 2012

Questions that CST can easily answer:

How quickly is untreated AGA getting worse? What percent per year?

Is it time to advance my patient from MNX to FIN?

Does FIN work as well if taken 2x per week?

Is MNX 2% bid equivalent to MNX 5% daily?

Is generic MNX equivalent to Rogaine?

Is MNX more effective with added RetinA?

Do HairMax and LaserCap work better than MNX?

Is there an added benefit of adding MNX and/or laser to FIN?

If I correct a patient’s iron deficiency, does her shedding improve?

Page 39: COHEN ppt 2012

Female patientWith low Serum Ferritin

4971 85

After 12 months ofIron supplement

Page 40: COHEN ppt 2012

Questions that CST can easily answer:

When has the woman with telogen effluvium stabilized?

My patient is convinced that MNX has made her “worse.”

How does FUE affect donor site density?

What percent improvement does my patient have after HT surgery?

Is this woman’s hair loss caused by shedding or AGA?

.

Page 41: COHEN ppt 2012

Patient with activeTelogen effluvium

4971 71

2 months later...still no improvement

Page 42: COHEN ppt 2012

Questions that CST can easily answer:

When has the woman with telogen effluvium stabilized?

My patient is convinced that MNX has made her “worse.”

How does FUE affect donor site density?

What percent improvement does my patient have after HT surgery?

Is this woman’s hair loss caused by shedding or AGA?

.

Page 43: COHEN ppt 2012

Baseline HMI, then4 months of MNX.

Phone call: “I’m much worse!”

4971 71

On re-examthe next day

she is no worse.

Page 44: COHEN ppt 2012

Questions that CST can easily answer:

When has the woman with telogen effluvium stabilized?

My patient is convinced that MNX has made her “worse.”

How does FUE affect donor site density?

What percent improvement does my patient have after HT surgery?

Is this woman’s hair loss caused by shedding or AGA?

.

Page 45: COHEN ppt 2012

7896

Pre-op FUE Post-op FUE

Page 46: COHEN ppt 2012

Questions that CST can easily answer:

When has the woman with telogen effluvium stabilized?

My patient is convinced that MNX has made her “worse.”

How does FUE affect donor site density?

What percent improvement does my patient have after HT surgery?

Is this woman’s hair loss caused by shedding or AGA?

.

Page 47: COHEN ppt 2012

Pre HT surgery

4945 78

Post HT surgery

Page 48: COHEN ppt 2012

Questions that CST can easily answer:

When has the woman with telogen effluvium stabilized?

My patient is convinced that MNX has made her “worse.”

How does FUE affect donor site density?

What percent improvement does my patient have after HT surgery?

Is this woman’s hair loss caused by shedding or AGA?

.

Page 49: COHEN ppt 2012

Woman with SHEDDING

68 67

Page 50: COHEN ppt 2012

Woman with Pattern loss (AGA)

NOTE – Hair loss will NOT be visible until HMI is less than 49

81 98

Page 51: COHEN ppt 2012

END